The Lancet Commission on prostate cancer: planning for the surge in cases

ND James, I Tannock, J N'Dow, F Feng, S Gillessen… - The Lancet, 2024 - thelancet.com
Executive summary Prostate cancer is the most common cancer in men in 112 countries,
and accounts for 15% of cancers. In this Commission, we report projections of prostate …

[HTML][HTML] Diagnostic performance of a magnetic resonance imaging-directed targeted plus regional biopsy approach in prostate cancer diagnosis: a systematic review …

MJ Hagens, MF Salamanca, AR Padhani… - European Urology Open …, 2022 - Elsevier
Context Systematic biopsies are additionally recommended to maximize the diagnostic
performance of the magnetic resonance imaging (MRI) diagnostic pathway for men with …

Targeted prostate biopsy: umbra, penumbra, and value of perilesional sampling

WG Brisbane, AM Priester, J Ballon, L Kwan, MK Delfin… - European urology, 2022 - Elsevier
Background Systematic prostate biopsies add to the cancer detection rate of targeted
biopsies, but the explanation for that increased sensitivity is not yet clear. Objective To …

Protocol for the TRANSLATE prospective, multicentre, randomised clinical trial of prostate biopsy technique

RJ Bryant, H Yamamoto, B Eddy, S Kommu… - BJU …, 2023 - Wiley Online Library
Objectives Primary objectives: to determine whether local anaesthetic transperineal prostate
(LATP) biopsy improves the detection of clinically significant prostate cancer (csPCa) …

Optimizing multiparametric magnetic resonance imaging-targeted biopsy and detection of clinically significant prostate cancer: the role of perilesional sampling

JP Noujeim, Y Belahsen, Y Lefebvre… - Prostate Cancer and …, 2023 - nature.com
Background The added-value of systematic biopsy (SB) in patients undergoing magnetic
resonance imaging (MRI)-targeted biopsy (TB) remains unclear and the spatial distribution …

Impact of magnetic resonance imaging targeting on pathologic upgrading and downgrading at prostatectomy: a systematic review and meta-analysis

IC Weinstein, X Wu, A Hill, D Brennan… - European Urology …, 2023 - Elsevier
Context The evidence supporting multiparametric magnetic resonance imaging (MRI)
targeting for biopsy is nearly exclusively based on biopsy pathologic outcomes. This is …

Likelihood of sampling prostate cancer at systematic biopsy as a function of gland volume and number of cores

ME Rezaee, KJ Macura, BJ Trock, A Herati… - Prostate Cancer and …, 2024 - nature.com
Background Pre-biopsy multiparametric magnetic resonance imaging (mpMRI) of the
prostate is used to conduct targeted prostate biopsy (TB), guided by ultrasound and …

Current role of systematic biopsy in diagnosis of clinically significant prostate cancer in primary combined MRI-targeted biopsy: a high-volume single-center study

P Krausewitz, D Fostitsch, R Weiten, N Kluemper… - World Journal of …, 2023 - Springer
Purpose Additive systematic biopsy (SB) contributes to prostate cancer (PCA) detection in
MRI-targeted biopsy (TB). However, the reasons for this are not yet clear. We compared the …

Combination of PI-RADS score and PSAD can improve the diagnostic accuracy of prostate cancer and reduce unnecessary prostate biopsies

C Wang, L Yuan, D Shen, B Zhang, B Wu… - Frontiers in …, 2022 - frontiersin.org
Objectives The purpose of this study is to evaluate the diagnostic accuracy of the clinical
variables of patients with prostate cancer (PCa) and to provide a strategy to reduce …

The Added Value of Side-specific Systematic Biopsy in Patients Diagnosed by Magnetic Resonance Imaging–targeted Prostate Biopsy

HA Bourgeno, T Jabbour, A Baudewyns… - European Urology …, 2024 - Elsevier
Background Systematic biopsy (SB) combined with magnetic resonance imaging (MRI)-
targeted biopsy is still recommended considering the risk of missing clinically significant …